The FY17 SCIRP CRDA is intended to support planning and development activities necessary to initiate a future clinical study with the potential to have a significant impact on SCIs.
The future study to be developed through the CRDA may be clinical research or a clinical trial (as defined in the
credit:
full announcement).
The FY17 SCIRP CRDA also encourages the inclusion of junior investigators on the research team.
Relevance of the research to military and/or Veteran populations affected by SCI is a key element of this award mechanism.
Collaboration with military or VA researchers and clinicians is highly encouraged.
Inclusion of active duty military or Veteran populations is very highly encouraged.
If the research will involve other populations, the relevance to the military or Veteran populations and the rationale for the inclusion of the other populations must be clearly articulated by the applicant.
SCIRP CRDA recipients are expected to be ready to apply for advanced funding in the program year following completion of their CRDA and are encouraged to apply for future SCIRP funding through an appropriate FY19 or FY20 SCIRP Program Announcement, if offered.
Release of FY19 or FY20 SCIRP Program Announcements and any subsequent awards will be contingent upon the availability of Federal funds for the program and competitive selection.
Award of an FY17 SCIRP CRDA is in no way an assurance of funding for a future SCIRP award(s).